Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Chemours (CC) EPS (Weighted Average and Diluted) (2016 - 2025)

Chemours has reported EPS (Weighted Average and Diluted) over the past 12 years, most recently at -$0.31 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.31 for Q4 2025, down 287.5% from a year ago — trailing twelve months through Dec 2025 was -$2.56 (down 668.89% YoY), and the annual figure for FY2025 was -$2.57, down 658.7%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.31 at Chemours, down from $0.31 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for CC hit a ceiling of $1.52 in Q3 2022 and a floor of -$2.53 in Q2 2025.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.34 (2025), compared with a mean of $0.17.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): skyrocketed 1163.64% in 2021 and later tumbled 748.72% in 2025.
  • Chemours' EPS (Weighted Average and Diluted) stood at $1.39 in 2021, then tumbled by 146.76% to -$0.65 in 2022, then skyrocketed by 81.54% to -$0.12 in 2023, then soared by 33.33% to -$0.08 in 2024, then plummeted by 287.5% to -$0.31 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.31 (Q4 2025), $0.31 (Q3 2025), and -$2.53 (Q2 2025) per Business Quant data.